SEPTInvestingStart Free

ORKA 10-Q: SEC filing

Oruka Therapeutics

Filed with the SEC on · accession 0001213900-26-117518

ORKA filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. Oruka Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results, equity award activity, and related-party agreements.

Summary of the filing

Oruka Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results, equity award activity, and related-party agreements. The filing includes standard XBRL-tagged financial data with no single material corporate event.

For details, click here →How to read a 10-Q →

Key details

FilerOruka Therapeutics, Inc.
Related party / counterpartyParagon
Related party / counterpartyParuka
Agreement counterpartyHalozyme Hypercon Inc.
Referenced partyFairmount
ExecutiveLaura Sandler
ExecutiveKristine Ball

✦ Ask GOAX AI about this filing — what it means for ORKA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ORKA?

Click here

Frequently asked questions

What did ORKA file with the SEC on Nov 9, 2026?

ORKA filed a 10-Q (SEC filing). Oruka Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results, equity award activity, and related-party agreements. The filing includes standard XBRL-tagged financial data with no single material corporate event.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other ORKA SEC filings

Get alerts when ORKA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ORKA overviewORKA analysisORKA newsLatest SEC filings